This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hübner, W.-D. Articles by Podzuweit, H. Search for Related Content PubMed PubMed Citation Articles by Hübner, W.-D. Articles by Podzuweit, H. Social Bookmarking                         What's this?

Hypericum Treatment of Mild Depressions with Somatic Symptoms

S. Lande

H. Podzuweit

In a randomized, placebo-controlled, double-blind study, 39 patients with depression with somatic symptoms were treated with hypericum extract LI 160. The therapy lasted for 4 weeks; the dosage was 300 mg three times daily. At the onset of the study as well as after 2 and 4 weeks, the following criteria were analyzed: HAMD, B-L, CGI, and vegetative symptoms. The results show a significant improvement in the active treatment group at the 5% level as compared to placebo. Seventy percent of the patients treated with LI 160 were free of symptoms after 4 weeks. Typical symptoms of the depression such as lack of activity, tiredness, fatigue, and disturbed sleep, were especially responsive. In no case were any undesirable side effects observed. (J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S12-S14).

Journal of Geriatric Psychiatry and Neurology, Vol. 7, No. 1, S12-S14 (1994)
DOI: 10.1177/089198879400700105


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Final Report on the Safety Assessment of Hypericum Perforatum Extract and Hypericum Perforatum Oil International Journal of Toxicology, January 1, 2001; 20(2_suppl): 31 - 39. [Abstract] [PDF]

				G. Harrer and V. Schulz Clinical Investigation of the Antidepressant Effectiveness of Hypericum J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S6 - S8. [Abstract] [PDF]

				H. Sommer and G. Harrer Placebo-Controlled Double-Blind Study Examining the Effectiveness of an Hypericum Preparation in 105 Mildly Depressed Patients J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S9 - S11. [Abstract] [PDF]

				K.-D. Hansgen, J. Vesper, and M. Ploch Multicenter Double-Blind Study Examining the Antidepressant Effectiveness of the Hypericum Extract LI 160 J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S15 - S18. [Abstract] [PDF]

				E.-U. Vorbach, W.-D. Hubner, and K.-H. Arnoldt Effectiveness and Tolerance of the Hypericum Extract LI 160 in Comparison with Imipramine: Randomized Double-Blind Study with 135 Outpatients J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S19 - S23. [Abstract] [PDF]

				G. Harrer, W.-D. Hubner, and H. Podzuweit Effectiveness and Tolerance of the Hypericum Extract LI 160 Compared to Maprotiline: A Multicenter Double-Blind Study J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S24 - S28. [Abstract] [PDF]

				H. Woelk, G. Burkard, and J. Grunwald Benefits and Risks of the Hypericum Extract LI 160: Drug Monitoring Study with 3250 Patients J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S34 - S38. [Abstract] [PDF]

				H. Schulz and M. Jobert Effects of Hypericum Extract on the Sleep EEG in Older Volunteers J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S39 - S43. [Abstract] [PDF]

				D. Johnson, H. Ksciuk, H. Woelk, E. Sauerwein-Giese, and A. Frauendorf Effects of Hypericum Extract LI 160 Compared with Maprotiline on Resting EEG and Evoked Potentials in 24 Volunteers J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S44 - S46. [Abstract] [PDF]